Quarterly Result13 Aug 2026, 04:15 pm
3B BlackBio Dx Declares Unaudited Q1 FY27 Results
AI Summary
3B BlackBio Dx Ltd announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these results, which were reviewed by the Audit Committee and had a Limited Review Report from the Statutory Auditors. The company also appointed M/s. Sanjay Kasliwal & Associates as Cost Auditor for FY 2026-27. The meeting commenced at 3:00 PM and concluded at 3:50 PM.
Key Highlights
- Unaudited standalone and consolidated results declared for Q1 FY27.
- Board approved financial results after Audit Committee review.
- Limited Review Report obtained from Statutory Auditors.
- Cost Auditor appointed for FY 2026-27.
- Board meeting held on August 13, 2026.
Price Impact
More from 3BBLACKBIO